Oak Harvest Investment Services grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,161 shares of the medical equipment provider’s stock after acquiring an additional 212 shares during the quarter. Oak Harvest Investment Services’ holdings in Intuitive Surgical were worth $2,459,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Baystate Wealth Management LLC increased its position in shares of Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares during the last quarter. MCF Advisors LLC boosted its holdings in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the period. Headinvest LLC purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $28,000. Able Wealth Management LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Atticus Wealth Management LLC boosted its holdings in Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 41 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.
Intuitive Surgical Stock Down 0.9 %
ISRG traded down $4.00 during trading on Thursday, hitting $434.81. 826,374 shares of the stock were exchanged, compared to its average volume of 1,473,994. The firm has a market capitalization of $154.23 billion, a P/E ratio of 78.49, a PEG ratio of 5.67 and a beta of 1.39. The stock has a fifty day moving average price of $407.60 and a two-hundred day moving average price of $385.43. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $448.10.
Insider Activity
In other news, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 1,498 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 26th. The shares were sold at an average price of $369.92, for a total value of $554,140.16. Following the completion of the sale, the executive vice president now owns 5,507 shares in the company, valued at $2,037,149.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,956 shares of company stock valued at $6,927,011. Company insiders own 0.80% of the company’s stock.
Analyst Ratings Changes
A number of brokerages recently commented on ISRG. Piper Sandler raised their target price on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a report on Friday, April 19th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. Robert W. Baird decreased their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research note on Friday, April 19th. Evercore ISI lifted their price objective on Intuitive Surgical from $385.00 to $425.00 and gave the company an “in-line” rating in a research note on Tuesday. Finally, Stifel Nicolaus lifted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $404.79.
Get Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Stock Splits, Do They Really Impact Investors?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Conference Calls and Individual Investors
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.